Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M M A, Elmazar"'
Publikováno v:
Clinical and Translational Oncology. 23:1979-1994
The year 2019 witnessed the first approval of an immune checkpoint inhibitor (ICI) for the management of triple negative breast cancers (TNBC) that are metastatic and programmed death ligand (PD)-L1 positive. Extensive research has focused on testing
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(10)
The year 2019 witnessed the first approval of an immune checkpoint inhibitor (ICI) for the management of triple negative breast cancers (TNBC) that are metastatic and programmed death ligand (PD)-L1 positive. Extensive research has focused on testing
Publikováno v:
Toxicological Sciences. 18:389-394
Autor:
M. M. A. Elmazar, H. Nau
Publikováno v:
Retinoids ISBN: 9783642636141
Vitamin A and metabolites (retinoids) control numerous processes which are critical for reproduction and development such as differentiation, proliferation, apoptosis and morphogenesis (De Luca et al. 1995). Evidence has accumulated since the discove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27a3c5d282d24050c6d461fa8d3f5afe
https://doi.org/10.1007/978-3-642-58483-1_16
https://doi.org/10.1007/978-3-642-58483-1_16